First Washington Corp Neuronetics, Inc. Transaction History

First Washington Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.73 - $4.81 $1.04 Million - $2.88 Million	599,455 Added 88.8%	1,274,540 $2.29 Million
Q1 2024 May 13, 2024	BUY	$2.68 - $4.8 $547,797 - $981,129	204,402 Added 43.43%	675,085 $3.21 Million
Q4 2023 Feb 14, 2024	SELL	$1.05 - $2.9 $42,538 - $117,487	-40,513 Reduced 7.93%	470,683 $1.36 Million
Q3 2023 Nov 13, 2023	BUY	$1.29 - $2.22 $19,157 - $32,969	14,851 Added 2.99%	511,196 $690,000
Q4 2022 Feb 13, 2023	BUY	$2.74 - $6.87 $98,549 - $247,093	35,967 Added 7.81%	496,345 $3.41 Million
Q2 2022 Aug 10, 2022	SELL	$2.09 - $3.71 $4,589 - $8,147	-2,196 Reduced 0.47%	460,378 $1.48 Million
Q1 2022 May 11, 2022	BUY	$2.84 - $4.52 $20,271 - $32,263	7,138 Added 1.57%	462,574 $1.4 Million
Q4 2021 Feb 10, 2022	SELL	$3.87 - $6.59 $22,728 - $38,703	-5,873 Reduced 1.27%	455,436 $2.03 Million
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $1.48 Million - $3.7 Million	237,907 Added 106.49%	461,309 $3.03 Million
Q1 2021 May 13, 2021	BUY	$10.6 - $21.27 $2.37 Million - $4.75 Million	223,402 New	223,402 $2.76 Million

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

Stay updated on First Washington Corp with notifications on news.